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 ABSTRACT
The incidence of congenital anomalies in children born to mothers under anticonvulsant
therapy has been studied, in 2536 women who gave birth to 3348 children. The follow up period
varied between 3 to 20 years. The mothers had received barbiturates, hydantoinates and
carbamezapine in various combinations. The incidence of congenital anomalies noted was only
41, a figure not greater than the incidence ofanomalies in the general population. A plea is made
that anticonvulsant therapy should not be discontinued during pregnancy in women with
seizures.
INTRODUCTION 
Women suffering from seizures become con-
cerned at the onset of pregnancy, about the
control of seizures, the proper development of
the foetus and possible complications during the
course of the pregnancy and delivery. Should
they start a pregnancy ? If one has occured,
should they continue it ? Do seizures increase in
pregnancy and will the development of the foetus
be affected ? Worldwide experience in the man-
agement of epileptic women with pregnancy has
shown that most of these anxieties are misplaced
and with proper counselling and adequate therapy,
pregnancy and childbirth could be smooth with-
out any problems.
One fact to be stressed is that proper seizure
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control is essential throughout. This emphasis
has become necessary as some obstetricians
unfortunately advise stoppage of the drugs the
moment they learn that the women is pregnant,
based on the fear that all anticonvulsant drugs are
teratogenic. If it is not the obstetrician, the
husband and the in-laws insist on the stoppage
result g in serious problems. The problems that
a young Indian woman faces under these circum-
stances is distressing.
Pregnancy is likely to cause an increase in
seizur s (Knight and Rhind 1975, Philbert and
Dam 1982), but more often this is due to stoppage
of the drugs or inadequate medication. (Schmidt
and over 1983). Generalised seizures occuring
during pregnancy can be hazardous to the mother
and child and specially if status epilepticus de-
velops. in a series of mothers with status
epilepticus, nine mothers and 14 infants died
(Teramo and Hillsema 1982). A single generalised
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convulsion may lead to a stillbirth (Higgins and
Commerford 1974). When the seizures are poorly
controlled, the complications of pregnancy are
likely to increase (Teramo and Hillsema 1982,
Yerby and Kopsell 1985).  
Thus it is obvious that anticonvulsant drugs
have to be continued throughout, but one would
like to known how teratogenic are these drugs. In
experimental animals these drugs were shown to
be teratogenic; but in the humans in the required
doses the evidence is not complete, though there
are reports of increased incidence of abnormali-
ties in treated mothers (Spiedel and Meadow,
1972). The Oxford Record Linkage Study re-
ported seventy abnormalities in every 1000 births
to epileptic mothers, two to four times the rate in
the general population. (Fedrick 1973). Large
doses of phenytoin may cause some develop
mental syndromes in the infant (Hanson and
Smith 1975). Trimethadione (no longer in use)
and sodium valproate (Lindhurst and Schmidt
1986) have been proved to have definite terato-
genie effects. But how frequent is the occurence
of congenital defects in women on other
anticonvulsant drugs :
A study of the possible teratogenicity of
anticonvulsants in epileptic mothers would in-
volve the following :
1. Proof that congenital malformations occur
in a significantly greater percentage in women
who are taking anticonvulsant drugs.
2. Proof that this increased incidence is due to
the drugs and not due the epileptic characteristics
itself or other factors like socioeconomic status,
dietary deficiencies and obstetric factors like
maternal age etc.
MATERIALS AND METHODS
An attempt has been made to study this prob-
lem by analysing the records of 3500 women who
got married during their treatment for epilepsy,
with a follow up period varying from 3 to 20
years. Of these, 2536 women had given birth to
3348 children. 1936 had one child, 388 had 212
had three children.
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The drugs given were as follows :
H d ntoinates alone 150 patients
Hydantoinates and barbiturates 1630 patients
Barbiturates alone 215 patients
Hydantoinates and
carbamezapine 246 patients
Carbameapine alone 340 patients
The number of congenital malformations seen
in this group of 2536 women with 3348 children
was only 41.
Table - I
Anticonvilsants and Congenital
Malformation
1960 - 1986
Congenital Anomalies Seen
Total number of children
Malformation seen at birth
Polydactyly
Talipes
Cardiovascular
Cleftlip
Meningomyelocele
Hydrocephalus
G . I .  T r a c t
Others
2865
5
7
8
5
4
3
2
2
5
Total 41
DISCUSSION
Studies conducted by the ICMR show that the
rates of congenital malformations in the normal
population vary between 18 - 32 per 1000.
The above studies show that the incidence of
congenital malformations in the general popula-
tion in India varies between 17 to 34 per thou-
sand in different Parts of the country. Taking the
Incidence of Congenital Malformations
Hospital based (live birth only)
No. of births Major malformation
per 1000
Bombay 1966-67 10,000 17.0
Bombay 1968- 72 12,360 18.7
Pondicherry 1971-72 3,46 21.0
Mean 8,595.3 18.9
Delhi 1969-73 7,590 26.2
Ballabgarh 1976- 77 2,409 34.1
Mean     4999.5 30.15
Table - III
Incidence of Congenital Malformation
Madras - M. S. Ramakrishnan Et Al
23000 consecutive births
1972 - 1974
(Hospital based)
Malformation children
Incidence of malformations
(including autopsy studies)
18.9 per 1000 births
30.7 per 1000 births
lowest incidence of 17 per thousand, the inci-
dence of congenital anomalies in the above
series of 3348 children should have been 46. It is
to be noted that the finding of 41 anomalies in
treated mothers in our series is less than the
expected average incidence in the general popu-
lation. Thus this study does not confirm the
observation of increased incidence of congenital
anomalies in mothers taking anticonvulsants.
It has to be mentioned here that the women
and children under this study belong to the
middle economic group whereas the figures in
 table II and III are from the lower socioeconomic
group. It is known that the socioeconomic status
influences the incidence of these anomalies more
of them occuring in the poorer groups. (Lawrence
et al 1980).
CONCLUSIONS
Considering all the various aspects, one may
suggest that sodium valproate should definitely
be avoided during pregnancy and the best therapy
may be with carbamezapine. Still there is a
problem as this drug is costly and in India many
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 women of lower socioeconomic status may not
be able to afford the high cost of continuous
carbamezapine medicationand will have to con-
tinue on hydantoinates and perhaps barbiturates.
The above study suggests that such a course need
not cause undue anxiety to the women or to their
obstetricians as the incidence of congenital
anomalies with the usual doses of hydantaoinates
and barbiturates does not seem to be higher that
the incidence in the general population.
One may conclude that during pregnancy, to
ensure safety of the mother and child,
anticonvulsant drugs should be continued at
adequate levels without any break; from our
available knowledge, though carbamezapine
would the best choice, hydantoinates and barbi-
turates may also be advised, when economics
precludes a large expense on costly drugs.
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